Jinliang Xing
- Molecular Biology top 1%
- Cancer Research top 0.5%
- Oncology top 2%
- Epidemiology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Topics
- Mitochondrial Function and Pathology (38 papers)Cancer, Hypoxia, and Metabolism (28 papers)Cancer Genomics and Diagnostics (24 papers)
- Journals
- SHILAP Revista de lepidopterologíaThe EMBO JournalGastroenterology
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Jinliang Xing
159 papers receiving 6.3k citations
Hit Papers
Peers
Comparison fields: 5 of 130
- Molecular Biology 4.0k
- Cancer Research 2.3k
- Oncology 1.0k
- Epidemiology 782
- Pulmonary and Respiratory Medicine 771
Countries citing papers authored by Jinliang Xing
This map shows the geographic impact of Jinliang Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinliang Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinliang Xing more than expected).
Fields of papers citing papers by Jinliang Xing
This network shows the impact of papers produced by Jinliang Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinliang Xing. The network helps show where Jinliang Xing may publish in the future.
Co-authorship network of co-authors of Jinliang Xing
This figure shows the co-authorship network connecting the top 25 collaborators of Jinliang Xing. A scholar is included among the top collaborators of Jinliang Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinliang Xing. Jinliang Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 84 | |
| 4 | 2 | |
| 5 | 34 | |
| 6 | miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 [Retraction] | 1 |
| 7 | miR-489-3p Inhibits Prostate Cancer Progression by Targeting DLX1 | 1 |
| 8 | 129 | |
| 9 | 39 | |
| 10 | 55 | |
| 11 | 152 | |
| 12 | 4 | |
| 13 | 21 | |
| 14 | 16 | |
| 15 | 16 | |
| 16 | 72 | |
| 17 | 31 | |
| 18 | 28 | |
| 19 | 63 | |
| 20 | 109 |
About Jinliang Xing
Jinliang Xing is a scholar working on Cancer Research, Molecular Biology and Hepatology, having authored 160 papers that have together received 6.3k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (38 papers), Cancer, Hypoxia, and Metabolism (28 papers) and Cancer Genomics and Diagnostics (24 papers). The work is most often cited by research in Cancer Research (2.3k citations), Molecular Biology (4.0k citations) and Hepatology (347 citations). Jinliang Xing has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Hushan Yang, Qichao Huang, Zhi‐Nan Chen, Xu Guo, Jibin Li, Tingting Ren, Shaogui Wan, Peng Yuan, Haiyan Cao and Yibing Chen. Their work appears in journals such as SHILAP Revista de lepidopterología, The EMBO Journal and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.